City of Hope Medical Center: Hematologic Neoplasms trials
The registry lists 20 Hematologic Neoplasms studies with City of Hope Medical Center as lead sponsor. 2 are open to participants now and 3 have results posted.
Phase 1 6Phase 2 3Phase 3 1No phase 10(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Wearable Data for Personalized Prognostication in Cancer: A Registry ProtocolNot yet recruitingNCT07691008
- Digital Health Intervention for Self-Management and Telemonitoring in Chimeric Antigen Receptor (CAR-T) TherapyRecruitingNCT07186192Phase 3
- Triplex Vaccine in Preventing CMV Infection in Patients Undergoing Hematopoietic Stem Cell TransplantationActive, not recruitingNCT04060277Phase 2Results posted
- CMV-MVA Triplex Vaccination of Stem Cell Donors in Preventing CMV Viremia in Participants With Allogeneic TransplantActive, not recruitingNCT03560752Phase 1Results posted
- High Dose Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil in Preventing Graft Versus Host Disease in Patients With Hematological Malignancies Undergoing Myeloablative or Reduced Intensity Donor Stem Cell TransplantCompletedNCT03128359Phase 2Results posted
- A Mobile Application, Oncpatient, to Assist Patients Undergoing Radiation TherapyActive, not recruitingNCT05173961Not applicable
- Reproducibility and Accuracy of a Portable System for Early Detection of Cardiac Dysfunction in Childhood Cancer SurvivorsActive, not recruitingNCT05138991Not applicable
- The Effect of Exercise and Nicotinamide Riboside Muscle Health and Insulin Resistance in Survivors of Childhood CancerActive, not recruitingNCT05023993Not applicable
- A Multidisciplinary Approach to Improve the Health of Older Adults With Blood Cancers After Stem Cell TransplantationActive, not recruitingNCT04914338Not applicable
- Flotetuzumab for the Treatment of Relapsed or Refractory Advanced CD123-Positive Hematological MalignanciesCompletedNCT04681105Phase 1
- 64Cu-DOTA-pembrolizumab PET for the Study of PD1 ExpressionWithdrawnNCT04605614Phase 1
- Cardiovascular Reserve Evaluation in Survivors of Transplant, CREST StudyActive, not recruitingNCT04537871
- Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell TransplantActive, not recruitingNCT04177004Phase 1
- CBM588 in Improving Clinical Outcomes in Patients Who Have Undergone Donor Hematopoietic Stem Cell TransplantActive, not recruitingNCT03922035Phase 1
- Psycho-Educational Cognition Intervention in Patients With Blood and Lymph CancerWithdrawnNCT03804164Not applicable
- Flotetuzumab in Treating Patients With Recurrent or Refractory CD123 Positive Blood CancerWithdrawnNCT03739606Phase 2
- Human Lysozyme Goat Milk in Treating Patients With Blood Cancer Undergoing Donor Stem Cell TransplantWithdrawnNCT03531281Phase 1
- Technology to Assess Vulnerable Older Adults With Cancer and Their CaregiversActive, not recruitingNCT02041416
- Quality of Life in Caregivers of Hospitalized Older Patients With CancerCompletedNCT01866969Not applicable
- Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell TransplantActive, not recruitingNCT01199562